logo

For the Inventor, By the Inventor

East Haven, CT, United States of America

Sudhirdas K Prayaga

This inventor holds 6 USPTO granted patents. Top assignee: Curagen Corporation. Active years: 2003-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sudhirdas K Prayaga. Retrieved from https://idiyas.com/inventor/sudhirdas-k-prayaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • O'Fallon, MO (US) (2003 - 2006)
  • East Haven, CT (US) (2005 - 2007)
  • Chesterfield, MO (US) (2007)

Company Filing History:

goldMedal6 out of 84 
 
Curagen Corporation
 patents

Years Active: 2003-2007

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7291483 - FGF-CX polynucleotide sequences and methods of producing same (2007-11-06),
2. 7253266 - Polypeptides of FGF-CX (2007-08-07),
3. 7056885 - Fibroblast growth factor and nucleic acids encoding same (2006-06-06),
4. 6992170 - Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin (2006-01-31),
5. 6855806 - Thymosin beta 10-like proteins and nucleic acids encoding same (2005-02-15),
6. 6600019 - Polypeptides and nucleic acids encoding same (2003-07-29),

Title: Sudhirdas K Prayaga: Innovator in Biotechnological Advancements

Introduction

Sudhirdas K Prayaga is a notable inventor based in East Haven, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and polynucleotides. With a total of 6 patents to his name, his work has implications for various medical applications.

Latest Patents

One of his latest patents is titled "FGF-CX polynucleotide sequences and methods of producing same." This invention provides FGF-CX, a novel isolated polypeptide, along with a polynucleotide encoding FGF-CX and antibodies that specifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide, or antibody. The invention also outlines methods in which the FGF-CX polypeptide, polynucleotide, and antibody can be utilized in the detection and treatment of a broad range of pathological states, as well as for other applications. Another patent, "Polypeptides of FGF-CX," reiterates the significance of FGF-CX and its potential uses in medical science.

Career Highlights

Sudhirdas K Prayaga has been associated with Curagen Corporation, where he has been instrumental in advancing biotechnological research. His innovative work has positioned him as a key figure in the development of therapeutic solutions.

Collaborations

He has collaborated with notable colleagues such as Richard August Shimkets and Michael Jeffers, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sudhirdas K Prayaga's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…